This site is intended for healthcare professionals
News

Gilead announces results from phase III trial of remdesivir in patients with moderate COVID-19.- Gilead Sciences.

Read time: 1 mins
Last updated:2nd Jun 2020
Published:2nd Jun 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register for free exclusive healthcare eLearning resources


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest